Ultragenyx Pharmaceutical Inc. Logo

Email this page: News Release

Ultragenyx Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

For security reasons, registration is required before you can use this feature.
* Indicates required field